About Us

Who We Are

Nanchang Antisunse Biopharmaceutical Co., Ltd. Limited is a bio-pharmaceutical company focusing on active pharmaceutical ingredients and intermediates synthesis research and development. Our mission is to improve people’s health through our innovation. Our pilot plant is built in the Biopharma Venture Park in Taicang, Jiangsu province. We have two contractual manufacturing bases in Jiangsu and Jiangxi province respectively.

Our unwavering commitment is to provide comprehensive and professional services to global pharmaceutical and biotech companies. Our core competences allow us to provide custom development services and custom manufacturing from grammes scale to tonnes scale.

Our confidence comes from the passionate team, especially the well educated and experienced R&D team, of which the members include doctor of pharmacy holders from top universities in US, and former scientists from the world leading pharmaceutical companies. We have a diverse portfolio of products including argatroban, rosuvastatin calcium and etc. As part of our strategy, we are continually expending our product portfolio and developing pipelines by taking the advantage of our strength.

Business Scope: Including pharmaceutical research and development, production, and sales; cosmetic research and development, production, and sales; research and development, production, and sales of pharmaceutical intermediates; technical services, technology transfer, and technical consultation; import and export of goods and technology.

Business Modules of the Company

New Drug Development: The company focuses on the research and development of drugs for autoimmune and inflammatory skin diseases. Its new drug project, Bcl-2 topical gel for the treatment of psoriasis, has now essentially completed preclinical studies. Bcl-2 inhibitors are a promising therapeutic approach. By inhibiting the activity of Bcl-2 protein, they can induce apoptosis of cancer cells and have also shown new application strategies in the treatment of immune skin diseases.

The Afanafine Phosphate project, as an innovative drug for ED treatment, has completed compound patent application.

Chemical Research and Production: The company produces chemicals such as Paroxetine, Pilocarpine, Levetiracetam, Berberine Hydrochloride, Bromelain, Quercetin, Tetracaine Mesylate, Entecavir, Agatolimod, and Triphenylsilanol. These chemicals have mature production processes.

Cosmetic Production and Sales: The company has launched an anti-aging and repair series of cosmetics, registered with the trademark antissenssie which have been well-received in the domestic market. The current anti-aging cosmetic market is experiencing rapid growth. In 2023, the market size of China's anti-aging industry was approximately RMB 152.18 billion, with RMB 94.82 billion attributed to anti-aging cosmetics. In the first half of 2024, the sales of anti-aging products in China's cosmetics market reached RMB 190.77 billion, an increase of 31.2% year-on-year, accounting for 40.1% of the market share.